These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7836016)

  • 21. The utility of the PRECEDE model in predicting HIV risk behaviors among Puerto Rican injection drug users.
    Deren S; Kang SY; Rapkin B; Robles RR; Andia JF; Colón HM
    AIDS Behav; 2003 Dec; 7(4):405-12. PubMed ID: 14707537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroconversion issues among out-of-treatment injection drug users.
    Fisher DG; Fenaughty AM; Trubatch B
    J Psychoactive Drugs; 1998; 30(3):299-305. PubMed ID: 9798796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual HIV risk: receptive syringe sharing and unprotected sex among HIV-negative injection drug users in New York City.
    Neaigus A; Reilly KH; Jenness SM; Hagan H; Wendel T; Gelpi-Acosta C
    AIDS Behav; 2013 Sep; 17(7):2501-9. PubMed ID: 23640654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors and HIV seropositivity among injecting drug users in Bangkok.
    Choopanya K; Vanichseni S; Des Jarlais DC; Plangsringarm K; Sonchai W; Carballo M; Friedmann P; Friedman SR
    AIDS; 1991 Dec; 5(12):1509-13. PubMed ID: 1814333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for HIV-1 seroprevalence among drug injectors in the cocaine-using environment of Rio de Janeiro.
    Lima ES; Friedman SR; Bastos FI; Telles PR; Friedmann P; Ward TP; des Jarlais DC
    Addiction; 1994 Jun; 89(6):689-98. PubMed ID: 8069170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV/AIDS risk perception, HIV risk behaviors, and HIV seropositivity among injection drug users in Puerto Rico.
    Cancel LI; Robles RR; Colón HM; Matos TD; Freeman DH
    P R Health Sci J; 1994 Jun; 13(2):153-8. PubMed ID: 7938402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An international comparative study of HIV prevalence and risk behaviour among drug injectors in 13 cities. WHO Collaborative Study Group.
    Bull Narc; 1993; 45(1):19-46. PubMed ID: 8305904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High HIV prevalence, suboptimal HIV testing, and low knowledge of HIV-positive serostatus among injection drug users in St. Petersburg, Russia.
    Niccolai LM; Toussova OV; Verevochkin SV; Barbour R; Heimer R; Kozlov AP
    AIDS Behav; 2010 Aug; 14(4):932-41. PubMed ID: 18843531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV seroconversion in intravenous drug users in San Francisco, 1985-1990.
    Moss AR; Vranizan K; Gorter R; Bacchetti P; Watters J; Osmond D
    AIDS; 1994 Feb; 8(2):223-31. PubMed ID: 8043227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for shooting gallery use among drug injectors in Puerto Rico.
    Reyes JC; Robles RR; Colón HM; Freeman DH; Sahai H; Matos TD
    P R Health Sci J; 1996 Sep; 15(3):227-31. PubMed ID: 8994289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safe sex? Misconceptions, gender differences and barriers among injection drug users: a focus group approach.
    Weiss SH; Weston CB; Quirinale J
    AIDS Educ Prev; 1993; 5(4):279-93. PubMed ID: 8297708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV prevalence and factors associated with HIV infection among male injection drug users under 30: a cross-sectional study in Long An, Vietnam.
    Tran TM; Nguyen HT; Yatsuya H; Hamajima N; Nishimura A; Ito K
    BMC Public Health; 2006 Oct; 6():248. PubMed ID: 17029648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attitudes toward HIV treatments influence unsafe sexual and injection practices among injecting drug users.
    Tun W; Celentano DD; Vlahov D; Strathdee SA
    AIDS; 2003 Sep; 17(13):1953-62. PubMed ID: 12960828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV seroprevalence among people with severe mental illness in the United States: a critical review.
    Cournos F; McKinnon K
    Clin Psychol Rev; 1997; 17(3):259-69. PubMed ID: 9160176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of drug injection in the spread of HIV in Argentina and Brazil.
    Libonatti O; Lima E; Peruga A; González R; Zacarías F; Weissenbacher M
    Int J STD AIDS; 1993; 4(3):135-41. PubMed ID: 8324042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroprevalence and demographic characteristics of injection drugs users among individuals at risk for HIV infection in Winnipeg, Manitoba, Canada.
    Hammond GW; Tate R; Buchanan D; Malazdrewicz R; Chochinov D; Sekla L; Elmslie K
    Clin Invest Med; 1991 Oct; 14(5):437-43. PubMed ID: 1742922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Needle sharing and participation in the Amsterdam Syringe Exchange program among HIV-seronegative injecting drug users.
    Hartgers C; van Ameijden EJ; van den Hoek JA; Coutinho RA
    Public Health Rep; 1992; 107(6):675-81. PubMed ID: 1454980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Operating needle exchange programmes in the hills of Thailand.
    Gray J
    AIDS Care; 1995; 7(4):489-99. PubMed ID: 8547363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV infection and AIDS among drug injectors at Rio de Janeiro: perspectives and unanswered questions.
    Lima ES; Bastos FI; Telles PR; Friedman SR
    Bull Narc; 1993; 45(1):107-15. PubMed ID: 8305901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knowledge, attitudes and behaviour among HIV-positive and HIV-negative clients of a confidential HIV counselling and testing centre in Thailand.
    Phanuphak P; Müller O; Sarangbin S; Sittitrai W
    AIDS; 1994 Sep; 8(9):1315-9. PubMed ID: 7802986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.